May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
The Role of Platelet Count in Decision–Making for Suspected Giant Cell Arteritis
C.S. Bouchard; A.Z. Ahmad; W.C. Park; B. Hayek; S. Blatt
Author Affiliations & Notes
  • C.S. Bouchard
    Ophthalmology, Loyola, Maywood, IL
  • A.Z. Ahmad
    Ophthalmology, Loyola, Maywood, IL
  • W.C. Park
    Ophthalmology, Loyola, Maywood, IL
  • B. Hayek
    Ophthalmology, Loyola, Maywood, IL
  • S. Blatt
    Ophthalmology, Loyola, Maywood, IL
  • Footnotes
    Commercial Relationships  C.S. Bouchard, None; A.Z. Ahmad, None; W.C. Park, None; B. Hayek, None; S. Blatt, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 785. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      The Role of Platelet Count in Decision–Making for Suspected Giant Cell Arteritis
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      C.S. Bouchard, A.Z. Ahmad, W.C. Park, B. Hayek, S. Blatt; The Role of Platelet Count in Decision–Making for Suspected Giant Cell Arteritis . Invest. Ophthalmol. Vis. Sci. 2006;47(13):785.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : To study the role of platelet count in the clinical work–up of giant cell arteritis (GCA), as suggested by a recently published model.

Methods: : The is a retrospective case review analysis. Patient data will be limited from 1995–2005, with final diagnosis confirmed by temporal artery biopsy. Patient laboratory data, in particular platelet count, will be applied to the "computer–based decision analytic model" and "pretest probability set" identified in the Niederkohr et al study: "Management of the Patient with Suspected Temporal Arteritis." (Ophthalmology. Vol 112, No 5, May 2005).

Results: : Thrombocytosis has been a more potent indicator of excluding GCA. Of 27 cases, only 6 (22.2%) patients with suspected GCA demonstrated thrombocytosis. 2 of these 6 (33.3%, or 7.41% of total) patients carried a final diagnosis of GCA, based on temporal artery biopsy. On the other hand, 17 (63.0%) of the 27 patients without thrombocytosis did not have GCA.

Conclusions: : Our preliminary data supports a portion of Niederkohr et al’s model. Platelet count is most effective in its absence; lack of thrombocytosis is associated with the exclusion of GCA.

Keywords: visual impairment: neuro-ophthalmological disease • inflammation • clinical laboratory testing 
© 2006, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2015 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×